001     282908
005     20251215105706.0
024 7 _ |a 10.1016/j.nicl.2025.103895
|2 doi
024 7 _ |a pmid:41176879
|2 pmid
024 7 _ |a pmc:PMC12621467
|2 pmc
037 _ _ |a DZNE-2025-01369
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Akdeniz, Aslı
|b 0
245 _ _ |a Lesion Network Mapping of Acute Neurological Deficits and Its Prognostic Value After Ischemic Stroke.
260 _ _ |a [Amsterdam u.a.]
|c 2025
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1765792458_22484
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Predicting functional recovery after ischemic stroke is vital for guiding clinical care. This study investigated whether lesion network mapping (LNM), a technique for modeling symptom-specific brain networks, can improve outcome prediction of functional recovery up to one-year post-stroke.We pooled data from two prospective stroke cohorts (1000Plus and PROSCIS-B; N = 565). Seven NIHSS-derived symptom networks were generated using LNM based on NIHSS sub-scores on admission (i.e., consciousness, language, motor, sensory, vision, neglect and ataxia). Lesion masks derived from MRI (within 7 days) were intersected with each symptom network to calculate individual network damage scores. Functional outcome was defined by the modified Rankin Scale (mRS) at 3 months (1000Plus) or 12 months (PROSCIS-B). Ordinal logistic regression models were performed to evaluate additional predictive value of LNM: Model 1 included age, lesion volume, and presence of selected neurological deficits; Model 2 included age, lesion volume, and NIHSS-derived network damage scores. Models were compared using pseudo-R2 and AIC.Patients had a mean age of 68 years and a median NIHSS of 3 (IQR 1-5). LNM revealed distinct, symptom-specific networks, with corresponding damage scores that were higher in patients exhibiting the respective deficits compared to those without. However, inclusion of these scores did not enhance the predictive accuracy of functional outcomes beyond that achieved with clinical variables alone (Model 1 vs. Model 2: pseudo-R2: 0.0468 vs. 0.0159; AIC:1730.598 vs. 1769.222).LNM-derived scores reflected symptom topography but did not enhance prediction of functional recovery. While promising as a mechanistic tool, the clinical utility of LNM-based damage metrics for prognostication remains limited and requires further validation.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Connectome
|2 Other
650 _ 7 |a Functional outcome
|2 Other
650 _ 7 |a Ischemic stroke
|2 Other
650 _ 7 |a Lesion-network mapping
|2 Other
650 _ 7 |a Stroke severity
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Ischemic Stroke: diagnostic imaging
|2 MeSH
650 _ 2 |a Ischemic Stroke: physiopathology
|2 MeSH
650 _ 2 |a Ischemic Stroke: complications
|2 MeSH
650 _ 2 |a Ischemic Stroke: pathology
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Prognosis
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging: methods
|2 MeSH
650 _ 2 |a Recovery of Function: physiology
|2 MeSH
650 _ 2 |a Nerve Net: diagnostic imaging
|2 MeSH
650 _ 2 |a Nerve Net: pathology
|2 MeSH
650 _ 2 |a Nerve Net: physiopathology
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Brain: diagnostic imaging
|2 MeSH
650 _ 2 |a Brain: pathology
|2 MeSH
700 1 _ |a Ríos, Ana Sofía
|b 1
700 1 _ |a Temuulen, Uchralt
|b 2
700 1 _ |a Fiebach, Jochen B
|b 3
700 1 _ |a Villringer, Kersten
|b 4
700 1 _ |a Ali, Huma Fatima
|b 5
700 1 _ |a Khalil, Ahmed
|b 6
700 1 _ |a Grittner, Ulrike
|b 7
700 1 _ |a Liman, Thomas G.
|0 P:(DE-2719)9000189
|b 8
|u dzne
700 1 _ |a Endres, Matthias
|0 P:(DE-2719)2811033
|b 9
|u dzne
700 1 _ |a Kufner, Anna
|b 10
773 _ _ |a 10.1016/j.nicl.2025.103895
|g Vol. 48, p. 103895 -
|0 PERI:(DE-600)2701571-3
|p 103895
|t NeuroImage: Clinical
|v 48
|y 2025
|x 2213-1582
856 4 _ |u https://pub.dzne.de/record/282908/files/DZNE-2025-01369.pdf
|y Restricted
856 4 _ |u https://pub.dzne.de/record/282908/files/DZNE-2025-01369.pdf?subformat=pdfa
|x pdfa
|y Restricted
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 8
|6 P:(DE-2719)9000189
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2811033
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEUROIMAGE-CLIN : 2022
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-04-12T14:49:23Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-04-12T14:49:23Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-04-12T14:49:23Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-01
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-01
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2025-01-01
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-01-01
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-01-01
920 1 _ |0 I:(DE-2719)1811005
|k AG Endres
|l Interdisciplinary Dementia Research
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)1811005
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21